nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Inappropriate antidiuretic hormone secretion—Chlorambucil—testicular cancer	0.0368	0.0368	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Vinblastine—testicular cancer	0.0337	0.0337	CcSEcCtD
Tolazamide—Digestion impaired—Chlorambucil—testicular cancer	0.032	0.032	CcSEcCtD
Tolazamide—Eruption—Dactinomycin—testicular cancer	0.0251	0.0251	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Ifosfamide—testicular cancer	0.0243	0.0243	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Cisplatin—testicular cancer	0.021	0.021	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Methotrexate—testicular cancer	0.02	0.02	CcSEcCtD
Tolazamide—Haemolytic anaemia—Chlorambucil—testicular cancer	0.0172	0.0172	CcSEcCtD
Tolazamide—Aplastic anaemia—Dactinomycin—testicular cancer	0.0145	0.0145	CcSEcCtD
Tolazamide—Pancytopenia—Chlorambucil—testicular cancer	0.0127	0.0127	CcSEcCtD
Tolazamide—Pancytopenia—Vinblastine—testicular cancer	0.0117	0.0117	CcSEcCtD
Tolazamide—Haemolytic anaemia—Ifosfamide—testicular cancer	0.0114	0.0114	CcSEcCtD
Tolazamide—Eruption—Methotrexate—testicular cancer	0.0109	0.0109	CcSEcCtD
Tolazamide—Agranulocytosis—Vinblastine—testicular cancer	0.0102	0.0102	CcSEcCtD
Tolazamide—Eruption—Epirubicin—testicular cancer	0.0102	0.0102	CcSEcCtD
Tolazamide—Pancytopenia—Bleomycin—testicular cancer	0.00985	0.00985	CcSEcCtD
Tolazamide—Haemolytic anaemia—Cisplatin—testicular cancer	0.0098	0.0098	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—testicular cancer	0.00941	0.00941	CcSEcCtD
Tolazamide—Pancytopenia—Dactinomycin—testicular cancer	0.00919	0.00919	CcSEcCtD
Tolazamide—Hyponatraemia—Cisplatin—testicular cancer	0.00888	0.00888	CcSEcCtD
Tolazamide—Pancytopenia—Ifosfamide—testicular cancer	0.00842	0.00842	CcSEcCtD
Tolazamide—Leukopenia—Chlorambucil—testicular cancer	0.00836	0.00836	CcSEcCtD
Tolazamide—Agranulocytosis—Dactinomycin—testicular cancer	0.00805	0.00805	CcSEcCtD
Tolazamide—Ill-defined disorder—Vinblastine—testicular cancer	0.00794	0.00794	CcSEcCtD
Tolazamide—Malaise—Vinblastine—testicular cancer	0.00772	0.00772	CcSEcCtD
Tolazamide—Vertigo—Vinblastine—testicular cancer	0.00769	0.00769	CcSEcCtD
Tolazamide—Leukopenia—Vinblastine—testicular cancer	0.00766	0.00766	CcSEcCtD
Tolazamide—Thrombocytopenia—Chlorambucil—testicular cancer	0.00746	0.00746	CcSEcCtD
Tolazamide—Agranulocytosis—Ifosfamide—testicular cancer	0.00738	0.00738	CcSEcCtD
Tolazamide—Pancytopenia—Cisplatin—testicular cancer	0.00726	0.00726	CcSEcCtD
Tolazamide—Erythema—Bleomycin—testicular cancer	0.00723	0.00723	CcSEcCtD
Tolazamide—Discomfort—Vinblastine—testicular cancer	0.0072	0.0072	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—testicular cancer	0.00712	0.00712	CcSEcCtD
Tolazamide—Thrombocytopenia—Vinblastine—testicular cancer	0.00684	0.00684	CcSEcCtD
Tolazamide—Erythema—Dactinomycin—testicular cancer	0.00674	0.00674	CcSEcCtD
Tolazamide—Dyspepsia—Chlorambucil—testicular cancer	0.00671	0.00671	CcSEcCtD
Tolazamide—Ill-defined disorder—Bleomycin—testicular cancer	0.00671	0.00671	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—testicular cancer	0.00665	0.00665	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00659	0.00659	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00658	0.00658	CcSEcCtD
Tolazamide—Fatigue—Chlorambucil—testicular cancer	0.00657	0.00657	CcSEcCtD
Tolazamide—Malaise—Bleomycin—testicular cancer	0.00652	0.00652	CcSEcCtD
Tolazamide—Leukopenia—Bleomycin—testicular cancer	0.00647	0.00647	CcSEcCtD
Tolazamide—Feeling abnormal—Chlorambucil—testicular cancer	0.00628	0.00628	CcSEcCtD
Tolazamide—Aplastic anaemia—Methotrexate—testicular cancer	0.00628	0.00628	CcSEcCtD
Tolazamide—Ill-defined disorder—Dactinomycin—testicular cancer	0.00625	0.00625	CcSEcCtD
Tolazamide—Erythema—Ifosfamide—testicular cancer	0.00618	0.00618	CcSEcCtD
Tolazamide—Discomfort—Bleomycin—testicular cancer	0.00608	0.00608	CcSEcCtD
Tolazamide—Malaise—Dactinomycin—testicular cancer	0.00608	0.00608	CcSEcCtD
Tolazamide—Urticaria—Chlorambucil—testicular cancer	0.00606	0.00606	CcSEcCtD
Tolazamide—Leukopenia—Dactinomycin—testicular cancer	0.00603	0.00603	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—testicular cancer	0.00587	0.00587	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—testicular cancer	0.00583	0.00583	CcSEcCtD
Tolazamide—Thrombocytopenia—Bleomycin—testicular cancer	0.00578	0.00578	CcSEcCtD
Tolazamide—Feeling abnormal—Vinblastine—testicular cancer	0.00576	0.00576	CcSEcCtD
Tolazamide—Ill-defined disorder—Ifosfamide—testicular cancer	0.00573	0.00573	CcSEcCtD
Tolazamide—Discomfort—Dactinomycin—testicular cancer	0.00567	0.00567	CcSEcCtD
Tolazamide—Malaise—Ifosfamide—testicular cancer	0.00557	0.00557	CcSEcCtD
Tolazamide—Vertigo—Ifosfamide—testicular cancer	0.00555	0.00555	CcSEcCtD
Tolazamide—Leukopenia—Ifosfamide—testicular cancer	0.00553	0.00553	CcSEcCtD
Tolazamide—Asthenia—Chlorambucil—testicular cancer	0.00547	0.00547	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—testicular cancer	0.00543	0.00543	CcSEcCtD
Tolazamide—Pruritus—Chlorambucil—testicular cancer	0.00539	0.00539	CcSEcCtD
Tolazamide—Thrombocytopenia—Dactinomycin—testicular cancer	0.00539	0.00539	CcSEcCtD
Tolazamide—Erythema—Cisplatin—testicular cancer	0.00533	0.00533	CcSEcCtD
Tolazamide—Discomfort—Ifosfamide—testicular cancer	0.0052	0.0052	CcSEcCtD
Tolazamide—Asthenia—Vinblastine—testicular cancer	0.00501	0.00501	CcSEcCtD
Tolazamide—Ill-defined disorder—Cisplatin—testicular cancer	0.00494	0.00494	CcSEcCtD
Tolazamide—Thrombocytopenia—Ifosfamide—testicular cancer	0.00494	0.00494	CcSEcCtD
Tolazamide—Feeling abnormal—Bleomycin—testicular cancer	0.00486	0.00486	CcSEcCtD
Tolazamide—Malaise—Cisplatin—testicular cancer	0.0048	0.0048	CcSEcCtD
Tolazamide—Leukopenia—Cisplatin—testicular cancer	0.00477	0.00477	CcSEcCtD
Tolazamide—Fatigue—Dactinomycin—testicular cancer	0.00474	0.00474	CcSEcCtD
Tolazamide—Urticaria—Bleomycin—testicular cancer	0.00469	0.00469	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—testicular cancer	0.00465	0.00465	CcSEcCtD
Tolazamide—Dizziness—Vinblastine—testicular cancer	0.00462	0.00462	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—testicular cancer	0.00456	0.00456	CcSEcCtD
Tolazamide—Feeling abnormal—Dactinomycin—testicular cancer	0.00453	0.00453	CcSEcCtD
Tolazamide—Nausea—Chlorambucil—testicular cancer	0.00453	0.00453	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—testicular cancer	0.00453	0.00453	CcSEcCtD
Tolazamide—Discomfort—Cisplatin—testicular cancer	0.00448	0.00448	CcSEcCtD
Tolazamide—Malaise—Etoposide—testicular cancer	0.0044	0.0044	CcSEcCtD
Tolazamide—Vertigo—Etoposide—testicular cancer	0.00438	0.00438	CcSEcCtD
Tolazamide—Headache—Vinblastine—testicular cancer	0.00438	0.00438	CcSEcCtD
Tolazamide—Leukopenia—Etoposide—testicular cancer	0.00437	0.00437	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Tolazamide—Fatigue—Ifosfamide—testicular cancer	0.00435	0.00435	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—testicular cancer	0.00431	0.00431	CcSEcCtD
Tolazamide—Thrombocytopenia—Cisplatin—testicular cancer	0.00426	0.00426	CcSEcCtD
Tolazamide—Asthenia—Bleomycin—testicular cancer	0.00423	0.00423	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—testicular cancer	0.00422	0.00422	CcSEcCtD
Tolazamide—Pruritus—Bleomycin—testicular cancer	0.00417	0.00417	CcSEcCtD
Tolazamide—Feeling abnormal—Ifosfamide—testicular cancer	0.00415	0.00415	CcSEcCtD
Tolazamide—Nausea—Vinblastine—testicular cancer	0.00415	0.00415	CcSEcCtD
Tolazamide—Discomfort—Etoposide—testicular cancer	0.0041	0.0041	CcSEcCtD
Tolazamide—Urticaria—Ifosfamide—testicular cancer	0.00401	0.00401	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—testicular cancer	0.00398	0.00398	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—testicular cancer	0.00395	0.00395	CcSEcCtD
Tolazamide—Asthenia—Dactinomycin—testicular cancer	0.00395	0.00395	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—testicular cancer	0.0039	0.0039	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—testicular cancer	0.00383	0.00383	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00375	0.00375	CcSEcCtD
Tolazamide—Pancytopenia—Epirubicin—testicular cancer	0.00373	0.00373	CcSEcCtD
Tolazamide—Rash—Bleomycin—testicular cancer	0.00372	0.00372	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—testicular cancer	0.00366	0.00366	CcSEcCtD
Tolazamide—Asthenia—Ifosfamide—testicular cancer	0.00362	0.00362	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00358	0.00358	CcSEcCtD
Tolazamide—Feeling abnormal—Cisplatin—testicular cancer	0.00358	0.00358	CcSEcCtD
Tolazamide—Pruritus—Ifosfamide—testicular cancer	0.00357	0.00357	CcSEcCtD
Tolazamide—Nausea—Bleomycin—testicular cancer	0.0035	0.0035	CcSEcCtD
Tolazamide—Agranulocytosis—Methotrexate—testicular cancer	0.00349	0.00349	CcSEcCtD
Tolazamide—Rash—Dactinomycin—testicular cancer	0.00347	0.00347	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—testicular cancer	0.00345	0.00345	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.00344	0.00344	CcSEcCtD
Tolazamide—Fatigue—Etoposide—testicular cancer	0.00343	0.00343	CcSEcCtD
Tolazamide—Dizziness—Ifosfamide—testicular cancer	0.00333	0.00333	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00332	0.00332	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—testicular cancer	0.00328	0.00328	CcSEcCtD
Tolazamide—Nausea—Dactinomycin—testicular cancer	0.00327	0.00327	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—testicular cancer	0.00327	0.00327	CcSEcCtD
Tolazamide—Rash—Ifosfamide—testicular cancer	0.00318	0.00318	CcSEcCtD
Tolazamide—Urticaria—Etoposide—testicular cancer	0.00316	0.00316	CcSEcCtD
Tolazamide—Asthenia—Cisplatin—testicular cancer	0.00312	0.00312	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—testicular cancer	0.00302	0.00302	CcSEcCtD
Tolazamide—Nausea—Ifosfamide—testicular cancer	0.00299	0.00299	CcSEcCtD
Tolazamide—Erythema—Methotrexate—testicular cancer	0.00292	0.00292	CcSEcCtD
Tolazamide—Asthenia—Etoposide—testicular cancer	0.00286	0.00286	CcSEcCtD
Tolazamide—Pruritus—Etoposide—testicular cancer	0.00282	0.00282	CcSEcCtD
Tolazamide—Rash—Cisplatin—testicular cancer	0.00274	0.00274	CcSEcCtD
Tolazamide—Erythema—Epirubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—testicular cancer	0.00271	0.00271	CcSEcCtD
Tolazamide—Malaise—Methotrexate—testicular cancer	0.00264	0.00264	CcSEcCtD
Tolazamide—Dizziness—Etoposide—testicular cancer	0.00263	0.00263	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—testicular cancer	0.00263	0.00263	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Tolazamide—Nausea—Cisplatin—testicular cancer	0.00258	0.00258	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—testicular cancer	0.00254	0.00254	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—testicular cancer	0.00253	0.00253	CcSEcCtD
Tolazamide—Rash—Etoposide—testicular cancer	0.00251	0.00251	CcSEcCtD
Tolazamide—Headache—Etoposide—testicular cancer	0.00249	0.00249	CcSEcCtD
Tolazamide—Malaise—Epirubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—testicular cancer	0.00246	0.00246	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Tolazamide—Nausea—Etoposide—testicular cancer	0.00237	0.00237	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—testicular cancer	0.00234	0.00234	CcSEcCtD
Tolazamide—Discomfort—Epirubicin—testicular cancer	0.0023	0.0023	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—testicular cancer	0.0021	0.0021	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Tolazamide—Urticaria—Methotrexate—testicular cancer	0.00189	0.00189	CcSEcCtD
Tolazamide—Feeling abnormal—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Tolazamide—Dyspepsia—Doxorubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Tolazamide—Asthenia—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Tolazamide—Feeling abnormal—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Tolazamide—Pruritus—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Tolazamide—Urticaria—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Tolazamide—Asthenia—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Tolazamide—Rash—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Tolazamide—Headache—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Tolazamide—Nausea—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Tolazamide—Rash—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Tolazamide—Headache—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Tolazamide—Dizziness—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Tolazamide—Nausea—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Tolazamide—Rash—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Tolazamide—Headache—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Tolazamide—Nausea—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
